Literature DB >> 22811810

Challenges toward personalized treatment of localized colorectal cancer.

Yi-Jen Chen1, Vincent Chung.   

Abstract

Entities:  

Year:  2010        PMID： 22811810      PMCID： PMC3397574          DOI： 10.3978/j.issn.2078-6891.2010.023

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN： 2078-6891


× No keyword cloud information.
  9 in total

1.  Bax expression is a candidate prognostic and predictive marker of colorectal cancer.

Authors:  Venkat R Katkoori; Catalina Suarez-Cuervo; Chandrakumar Shanmugam; Nirag C Jhala; Tom Callens; Ludwine Messiaen; James Posey; Harvey L Bumpers; Sreelatha Meleth; William E Grizzle; Upender Manne
Journal:  J Gastrointest Oncol       Date:  2010-12

2.  p53 point mutations and thymidylate synthase messenger RNA levels in disseminated colorectal cancer: an analysis of response and survival.

Authors:  H J Lenz; K Hayashi; D Salonga; K D Danenberg; P V Danenberg; R Metzger; D Banerjee; J R Bertino; S Groshen; L P Leichman; C G Leichman
Journal:  Clin Cancer Res       Date:  1998-05       Impact factor: 12.531

3.  Prognostic significance of Bax protein expression in diffuse aggressive non-Hodgkin's lymphoma.

Authors:  R D Gascoyne; M Krajewska; S Krajewski; J M Connors; J C Reed
Journal:  Blood       Date:  1997-10-15       Impact factor: 22.113

4.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

5.  Analysis of the p53/BAX pathway in colorectal cancer: low BAX is a negative prognostic factor in patients with resected liver metastases.

Authors:  I Sturm; C H Köhne; G Wolff; H Petrowsky; T Hillebrand; S Hauptmann; M Lorenz; B Dörken; P T Daniel
Journal:  J Clin Oncol       Date:  1999-05       Impact factor: 44.544

6.  Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3.

Authors:  H Zou; W J Henzel; X Liu; A Lutschg; X Wang
Journal:  Cell       Date:  1997-08-08       Impact factor: 41.582

7.  BAX protein expression and clinical outcome in epithelial ovarian cancer.

Authors:  Y T Tai; S Lee; E Niloff; C Weisman; T Strobel; S A Cannistra
Journal:  J Clin Oncol       Date:  1998-08       Impact factor: 44.544

8.  Reduced expression of proapoptotic gene BAX is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma.

Authors:  S Krajewski; C Blomqvist; K Franssila; M Krajewska; V M Wasenius; E Niskanen; S Nordling; J C Reed
Journal:  Cancer Res       Date:  1995-10-01       Impact factor: 12.701

9.  Prognostic value of thymidylate synthase, Ki-67, and p53 in patients with Dukes' B and C colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project collaborative study.

Authors:  Carmen J Allegra; Soon Paik; Linda H Colangelo; Allyson L Parr; Ilan Kirsch; George Kim; Pamela Klein; Patrick G Johnston; Norman Wolmark; H Samuel Wieand
Journal:  J Clin Oncol       Date:  2003-01-15       Impact factor: 44.544
  9 in total
  3 in total

1.  Bax is involved in the anticancer activity of Velcade in colorectal cancer.

Authors:  Liya Su; Qimuge Suyila; Ling Yang; Hong Li; Yaguang Xi; Xiulan Su
Journal:  Exp Ther Med       Date:  2017-07-31       Impact factor: 2.447

2.  Expression of PEBP4 protein correlates with the invasion and metastasis of colorectal cancer.

Authors:  Hongyi Liu; Qingling Kong; Bing Li; Yuanxiang He; Peng Li; Baoqing Jia
Journal:  Tumour Biol       Date:  2011-11-29

3.  Preoperative radiotherapy combined with capecitabine chemotherapy in Chinese patients with locally advanced rectal cancer.

Authors:  Jianhua Jin; Hua Meng; Guanghua Zhou; Xuezhong Xu; Zhixin Xue; Xiyuan Xu; Fang Wang; Wenbin Lu; Xianwen Li; Hua Zhang; Jianzhong Deng
Journal:  J Gastrointest Surg       Date:  2011-07-28       Impact factor: 3.452
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.